查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1926772

按活性成分、配方、價格範圍、應用和通路的藥用漱口水市場—2026-2032年全球預測

Pharmaceutical Mouthwash Market by Active Ingredient, Formulation, Price Tier, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，藥用漱口水市場價值將達到 30.5 億美元，到 2026 年將成長至 31.9 億美元，到 2032 年將達到 41.7 億美元，年複合成長率為 4.53%。

關鍵市場統計數據
基準年 2025 30.5億美元
預計年份：2026年 31.9億美元
預測年份 2032 41.7億美元
複合年成長率 (%) 4.53%

受臨床需求、消費者偏好和分銷管道創新等因素的驅動，漱口水市場正迅速發展。配方科學、牙科實踐和零售分銷等各方相關人員正在重新定義產品價值提案，以平衡抗菌功效、患者耐受性和天然性認知。同時，監管機構日益關注消毒劑安全性和抗生素合理使用，迫使生產商重新評估其活性成分策略和標籤標註方式。

具體而言，研發團隊必須在應對日益複雜的供應鏈的同時，將臨床終點與消費者利益結合。製造商正積極最佳化防腐體系和風味配方，以提高依從性，尤其是在牙科手術後患者和牙周病患者等弱勢群體中。同時，臨床醫生和牙科網路正在採用實證通訊協定來影響採購政策和產品推薦，從而加強臨床療效與商業性應用之間的關聯。因此，能夠同時展現臨床嚴謹性和消費者吸引力的公司，更有可能與專業合作夥伴和零售合作夥伴建立更牢固、更長期的合作關係。

抗菌藥物管理、消費者期望、數位商務、日益嚴格的監管以及供應鏈韌性正在重新定義該行業的競爭優勢。

漱口水產業正在加速經歷多項變革。首先，抗菌藥物管理與療效需求之間的平衡，促使人們對傳統活性成分（如氯化十六烷基吡啶和氯己定）進行更嚴格的審查，同時也推動了人們對替代療法（包括精油和草藥萃取物）的興趣。其次，主導兼具臨床療效和感官體驗的產品的需求日益成長，正在重塑藍圖，除了傳統的液體漱口水外，調味凝膠和特製凝膠產品也成為研發重點。

評估近期關稅調整對整個產業的採購決策、製造地和通路定價策略的影響

2025年實施的關稅調整帶來的累積影響，正促使整個漱口水產業在採購、配方經濟性和定價策略方面面臨新的挑戰。進口成本壓力迫使多家製造商重新審視其原料採購策略，轉向關鍵活性成分和輔料的區域供應商，以減輕關稅波動的影響。因此，採購團隊正在進行更細緻的成本效益分析和情境規劃，以在確保產品效能的同時，維持利潤率。

深度細分分析揭示了成分、應用、配方、通路和價格點如何驅動不同的開發和商業化路徑。

基於細分市場的洞察揭示了活性成分、應用、配方、分銷管道和價格點等方面的細微機會和獨特的營運需求。諸如氯化十六烷基吡啶、氯己定、精油、氟化物和草藥萃取物等活性成分具有不同的特性，因此需要根據臨床結果客製化活性成分策略。每種成分的特性都有不同的證據要求和耐受性考量，這會影響標籤和專家建議。特定應用途徑，例如一般口腔衛生、牙周護理、術後護理和美白，都受到不同的監管要求和臨床證據閾值。這意味著產品開發時間表和研究設計必須根據預期用途進行調整。

區域策略差異和業務重點影響全球主要地區的產品開發、監管規劃和分銷管道投資

區域趨勢正在以不同的方式影響美洲、歐洲、中東和非洲以及亞太地區的產品組合優先事項、監管策略和分銷投資。在美洲，完善的臨床指南和在牙科專業管道的強大影響力為臨床檢驗配方和高階定位創造了有利環境，而電子商務的滲透則補充了傳統的藥局和超級市場分銷管道，並支持開展有針對性的消費者教育宣傳活動。

製造商如何結合臨床投資、配方差異化和分銷管道合作來提升產品價值並增強其競爭優勢

在漱口水領域，製藥公司正透過臨床證據的累積、精準的產品組合細分以及針對特定管道的市場推廣模式，加速實現差異化。主要企業正投資於超越短期療效的臨床項目，涵蓋耐受性、微生物群影響和長期安全性等方面，從而為專家支持和高階產品宣稱奠定堅實基礎。同時，一些公司正利用其配方科學能力，打造差異化的感官體驗和緩釋機制，以提高產品留存率。

整合臨床檢驗、產品系列清晰度、全通路部署和供應鏈韌性的可操作策略重點

產業領導者應採取協調一致的策略，整合科學可信度、以消費者為中心的設計、針對特定管道的商業化以及穩健的供應鏈結構。首先，應優先進行能夠同時解決療效和耐受性終點的臨床項目（包括評估微生物組效應和長期安全性的研究），以獲得專家支持並為高價定價提供基礎。其次，應設計能夠清楚匹配活性成分特性和製劑形式與特定用途（例如牙周護理、術後恢復、美白和日常口腔衛生）的產品系列，以減少管道摩擦，並提高處方醫生和消費者的認知度。

為了支持結論，採用了穩健的混合方法研究途徑，結合了專家訪談、監管審查、臨床證據評估和跨區域營運分析。

本摘要的研究基礎是對一手和二手證據進行系統性綜合分析，以確保其見解能夠反映真實世界的實踐和臨床趨勢。一級資訊來源包括對製劑科學家、牙科專家、臨床網路採購人員以及負責零售和電商管道的商業高管的訪談。此外，還查閱了監管指導文件、臨床試驗註冊資料、專利文獻和上市公司披露資訊，以檢驗產品聲明和研發軌跡。

對策略要務的最終總結強調了整合臨床、商業和營運協作以實現永續優勢的必要性。

總之，漱口水市場正從以產品為中心的市場模式向以證據主導、通路意識強的生態系統轉型，臨床可靠性、配方創新和營運彈性決定著競爭優勢。那些將嚴謹的臨床檢驗與以消費者為導向的感官設計相結合，同時投資於全通路能力和供應鏈韌性的公司，將更有能力滿足不斷變化的臨床醫生期望和消費者偏好。監管趨勢和貿易環境雖然增加了市場的複雜性，但也為那些能夠快速提供品質保證且符合當地需求的產品的公司創造了新的機會。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依活性成分分類的藥用漱口水市場

  • 氯化十六烷基吡啶鎓
  • 氯己定
  • 精油
  • 氟化物
  • 草藥萃取物
  • 其他

9. 按配方分類的藥用漱口水市場

  • 形式
  • 凝膠
    • 調味凝膠
    • 無香凝膠
  • 漱口水
  • 噴

第10章：以價格範圍分類的藥用漱口水市場

  • 經濟
  • 中檔
  • 優質的

第11章 依應用分類的藥用漱口水市場

  • 一般口腔衛生
  • 牙周病治療
  • 術後護理
  • 美白

第12章 按通路分類的藥用漱口水市場

  • 便利商店
  • 牙醫診所和醫院
  • 線上零售
    • 品牌官方網站
    • 網路藥房
    • 市場
  • 藥局
    • 連鎖藥局
    • 獨立藥房
  • 超級市場/大賣場

13. 按地區分類的藥用漱口水市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的藥用漱口水市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國藥用漱口水市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國藥用漱口水市場

第17章：中國藥用漱口水市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Caldwell Consumer Products Corp.
  • Church & Dwight Co., Inc.
  • Colgate-Palmolive Company
  • Haleon plc
  • Johnson & Johnson
  • Kao Corporation
  • LG Household & Health Care Ltd.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Rhydburg Pharmaceuticals Ltd.
  • Sanofi SA
  • Skan INC.
  • The Procter & Gamble Company
Product Code: MRR-4F7A6D4FF2E2

The Pharmaceutical Mouthwash Market was valued at USD 3.05 billion in 2025 and is projected to grow to USD 3.19 billion in 2026, with a CAGR of 4.53%, reaching USD 4.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.05 billion
Estimated Year [2026] USD 3.19 billion
Forecast Year [2032] USD 4.17 billion
CAGR (%) 4.53%

The pharmaceutical mouthwash landscape is undergoing rapid evolution driven by clinical priorities, consumer preferences, and channel innovation. Stakeholders across formulation science, dental practice, and retail distribution are redefining product value propositions to balance antimicrobial efficacy, patient tolerability, and perceived naturalness. At the same time, heightened regulatory attention on antiseptic safety and antimicrobial stewardship is prompting manufacturers to reassess active ingredient strategies and labeling claims.

In practice, this means research and development teams must align clinical endpoints with consumer-facing benefits while navigating increasingly complex supply chains. Manufacturers are actively optimizing preservative systems and flavor profiles to improve compliance, particularly among vulnerable patient groups such as postoperative dental patients and those with periodontal disease. Concurrently, clinicians and dental networks are adopting evidence-based protocols that influence procurement preferences and product endorsements, creating a closer link between clinical validation and commercial uptake. As a result, companies that can demonstrate both clinical rigor and consumer appeal are positioned to build stronger, longer-lasting relationships with professional and retail partners.

How antimicrobial stewardship, consumer sensory expectations, digital commerce, regulatory intensity, and supply chain resilience are redefining competitive advantage in the category

Several transformative shifts are accelerating change across the pharmaceutical mouthwash ecosystem. First, the interplay between antimicrobial stewardship and efficacy demands has elevated scrutiny of traditional actives such as cetylpyridinium chloride and chlorhexidine, and has simultaneously fueled interest in alternative modalities, including essential oils and herbal extracts. Second, consumer-driven demand for products that combine clinical benefits with perceptible sensory experience has prioritized flavored and specialty gels alongside conventional liquid rinses, reshaping R&D roadmaps.

In addition, digital commerce and omnichannel distribution are altering purchase behaviors, with online retail platforms enabling targeted education, subscription models, and replenishment programs that increase repeat purchase potential. Regulatory bodies are also intensifying review pathways, requiring more robust safety data for long-term use claims, which is prompting companies to invest in clinical trials and post-market surveillance. Finally, supply chain resilience and raw material traceability are now core corporate priorities, driving nearshoring and supplier diversification initiatives that influence product cost structures and launch timelines. Taken together, these forces are redefining competitive advantage in the category

Assessment of how recent tariff adjustments have reshaped sourcing decisions, manufacturing footprints, and channel pricing strategies across the sector

The cumulative effects of tariff changes implemented in 2025 have introduced new considerations for sourcing, formulation economics, and pricing strategies across the pharmaceutical mouthwash sector. Import cost pressures have prompted several manufacturers to revisit ingredient sourcing decisions, moving toward regional suppliers for critical actives and excipients in order to reduce exposure to tariff volatility. As a result, procurement teams are engaging in more granular cost-to-serve analysis and scenario planning to preserve margin integrity while maintaining product performance specifications.

Moreover, these trade adjustments have influenced channel strategies, with some firms prioritizing domestic manufacturing for products destined for institutional buyers such as dental clinics and hospitals to avoid cross-border cost escalation. At the same time, online retail channels have absorbed a portion of price sensitivity through promotion mechanics and subscription offerings that smooth price perception for end consumers. The broader implication is that organizations with flexible manufacturing footprints and adaptive pricing frameworks are better positioned to absorb tariff-induced disruption while preserving strategic investments in innovation and clinical validation

Deep segmentation insights revealing how ingredients, applications, formulations, channels, and price tiers drive distinct development and commercial pathways

Segmentation-driven insight reveals nuanced opportunities and distinct operational requirements across active ingredient, application, formulation, distribution channel, and price tier axes. Active ingredient strategy must be tailored to the desired clinical outcome, given the varied properties of cetylpyridinium chloride, chlorhexidine, essential oils, fluoride, herbal extracts, and other actives; each profile carries different evidence expectations and tolerance considerations that will affect labeling and professional endorsement. Application-specific pathways, including general oral hygiene, periodontal treatment, postoperative care, and whitening, impose divergent regulatory and clinical evidence thresholds, meaning product development timelines and trial designs must be calibrated to the intended use case.

Formulation choices are similarly consequential: foam, gel, liquid rinse, and spray formats create unique consumer experiences and dispensing needs, and within gel formats the distinction between flavored and non-flavored variants can materially influence acceptance among sensitive patient cohorts. Distribution strategy requires a differentiated approach as well, since convenience stores, dental clinics and hospitals, online retail channels, pharmacies, and supermarkets or hypermarkets each operate under distinct procurement dynamics and merchandising constraints. Online retail further fragments into brand-owned websites, e-pharmacies, and large marketplaces, while pharmacy distribution differentiates between chain and independent operators; each sub-channel demands tailored marketing, pricing, and service models. Finally, price tier positioning across economy, mid-range, and premium segments shapes formulation complexity, packaging sophistication, and promotional tolerance, necessitating clear trade-offs between cost efficiency and perceived clinical or sensory superiority

Regional strategic differences and operational priorities that influence product development, regulatory planning, and channel investments across major global regions

Regional dynamics are shaping portfolio priorities, regulatory strategies, and distribution investments in distinct ways across the Americas, Europe Middle East and Africa, and Asia-Pacific regions. In the Americas, established clinical guidelines and a strong presence of dental professional channels create a favorable environment for clinically validated formulations and premium positioning, while e-commerce penetration complements traditional pharmacy and supermarket distribution, enabling targeted direct-to-consumer educational campaigns.

Across Europe, the Middle East and Africa, regulatory heterogeneity requires more complex market entry planning, with compliance and clinical evidence needs varying markedly between jurisdictions; this drives a focus on harmonized labeling strategies and adaptive regulatory affairs resourcing. In contrast, the Asia-Pacific region is characterized by rapid retail modernization and strong demand for herbal and natural ingredient platforms, which encourages innovation in herbal extracts and essential oil-based formulations. Additionally, manufacturing capacity in Asia-Pacific plays a central role in global supply chains, prompting companies to balance local demand fulfillment with export considerations and to prioritize quality assurance and supplier verification processes to meet international standards

How manufacturers are combining clinical investment, formulation differentiation, and channel partnerships to elevate product value and strengthen competitive moats

Companies operating in the pharmaceutical mouthwash category are increasingly differentiating through a combination of clinical evidence generation, targeted portfolio segmentation, and channel-specific go-to-market models. Leading manufacturers are investing in clinical programs that extend beyond acute efficacy to include tolerability, microbiome impact, and long-term safety, thereby creating stronger bases for professional endorsement and premium claims. Simultaneously, some organizations are leveraging technological capabilities in formulation science to deliver differentiated sensory profiles and sustained-release mechanisms that enhance adherence.

On the commercial front, strategic partnerships with dental networks and hospital procurement organizations are becoming more prevalent, enabling co-developed clinical pathways and preferred supplier relationships. At the same time, companies are experimenting with direct-to-consumer education strategies through online channels to build brand trust and drive repeat behavior. Operationally, investment in flexible manufacturing platforms, enhanced quality controls, and supplier traceability is becoming a competitive necessity, particularly where regulatory complexity and tariff exposure require rapid response to sourcing constraints. Together, these company-level moves signal a maturation of the category from commodity transactions toward evidence-backed, multi-channel commercial models

Actionable strategic priorities for companies to synchronize clinical validation, portfolio clarity, omnichannel execution, and supply chain resilience

Industry leaders should pursue a coordinated strategy that aligns scientific credibility with consumer-centric design, channel-specific commercialization, and resilient supply chain architecture. First, prioritize clinical programs that address both efficacy and tolerability endpoints, including studies that evaluate microbiome effects and long-term safety, in order to secure professional endorsements and justify premium positioning. Second, design product portfolios that clearly map active ingredient profiles and formulation formats to specific applications such as periodontal care, postoperative recovery, whitening, and everyday hygiene, thereby reducing channel friction and improving clarity for prescribers and consumers.

Third, accelerate digital and omnichannel capabilities by investing in educational content, subscription fulfillment, and targeted promotional mechanics that increase lifetime customer value. Fourth, enhance supply chain resilience by diversifying suppliers, qualifying regional manufacturing partners, and building ingredient traceability into procurement contracts to mitigate tariff and geopolitical risk. Fifth, tailor go-to-market approaches for each distribution channel segment, recognizing the differing requirements of dental clinics, pharmacies, supermarkets, convenience stores, and online sub-channels. Finally, incorporate adaptive pricing strategies across economy, mid-range, and premium tiers to preserve access while protecting margins for innovation-driven products

Robust mixed-methods research approach blending expert interviews, regulatory reviews, clinical evidence assessment, and cross-regional operational analysis to underpin conclusions

The research underpinning this summary combined a structured synthesis of primary and secondary evidence to ensure findings reflect operational realities and clinical trends. Primary inputs included interviews with formulation scientists, dental professionals, procurement leads within clinical networks, and commercial executives responsible for retail and e-commerce channels. These conversations were complemented by a review of regulatory guidance documents, clinical study registries, patent literature, and publicly available company disclosures to validate product claims and development trajectories.

Secondary analysis incorporated cross-regional comparisons of regulatory approaches and distribution models, and operational assessment of manufacturing footprints and supplier relationships. Data triangulation was applied to reconcile differing viewpoints, with emphasis placed on clinical endpoints, adoption dynamics within professional channels, and observable changes in distribution behavior. Quality controls included source verification, consistency checks across independent expert interviews, and a rigorous audit trail documenting the provenance of strategic assertions to support actionable recommendations

Final synthesis of strategic imperatives highlighting the necessity of integrated clinical, commercial, and operational alignment to capture durable advantage

In conclusion, the pharmaceutical mouthwash category is transitioning from a product-centered marketplace to an evidence-driven, channel-aware ecosystem where clinical credibility, formulation innovation, and operational agility determine competitive standing. Companies that integrate rigorous clinical validation with consumer-oriented sensory design, while simultaneously investing in omnichannel capabilities and supply chain resilience, will be best positioned to meet evolving clinician expectations and consumer preferences. Regulatory developments and trade dynamics add layers of complexity, but they also create opportunities for firms that can respond quickly with quality-assured, locally relevant offerings.

Looking forward, success will favor organizations that adopt a systems-level perspective-aligning R&D, regulatory, manufacturing, and commercial teams around clear segmentation strategies and measurable adoption metrics. By doing so, firms can convert insight into durable advantages across professional and consumer channels

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Mouthwash Market, by Active Ingredient

  • 8.1. Cetylpyridinium Chloride
  • 8.2. Chlorhexidine
  • 8.3. Essential Oils
  • 8.4. Fluoride
  • 8.5. Herbal Extracts
  • 8.6. Miscellaneous

9. Pharmaceutical Mouthwash Market, by Formulation

  • 9.1. Foam
  • 9.2. Gel
    • 9.2.1. Flavored Gel
    • 9.2.2. Non Flavored Gel
  • 9.3. Liquid Rinse
  • 9.4. Spray

10. Pharmaceutical Mouthwash Market, by Price Tier

  • 10.1. Economy
  • 10.2. Mid Range
  • 10.3. Premium

11. Pharmaceutical Mouthwash Market, by Application

  • 11.1. General Oral Hygiene
  • 11.2. Periodontal Treatment
  • 11.3. Postoperative Care
  • 11.4. Whitening

12. Pharmaceutical Mouthwash Market, by Distribution Channel

  • 12.1. Convenience Stores
  • 12.2. Dental Clinics & Hospitals
  • 12.3. Online Retail
    • 12.3.1. Brand Websites
    • 12.3.2. E Pharmacies
    • 12.3.3. Marketplace
  • 12.4. Pharmacy
    • 12.4.1. Chain Pharmacies
    • 12.4.2. Independent Pharmacies
  • 12.5. Supermarket/Hypermarket

13. Pharmaceutical Mouthwash Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Mouthwash Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Mouthwash Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Mouthwash Market

17. China Pharmaceutical Mouthwash Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Caldwell Consumer Products Corp.
  • 18.6. Church & Dwight Co., Inc.
  • 18.7. Colgate-Palmolive Company
  • 18.8. Haleon plc
  • 18.9. Johnson & Johnson
  • 18.10. Kao Corporation
  • 18.11. LG Household & Health Care Ltd.
  • 18.12. Prestige Consumer Healthcare Inc.
  • 18.13. Reckitt Benckiser Group plc
  • 18.14. Rhydburg Pharmaceuticals Ltd.
  • 18.15. Sanofi S.A.
  • 18.16. Skan INC.
  • 18.17. The Procter & Gamble Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)